Scientists have long been racking their brains to crack the mechanism behind Alzheimer’s disease progression. They may have finally found a crucial clue. A research team from Heidelberg University in Germany recently uncovered a hidden “switch” that acts like a death trigger for brain cells and plays a key role in cognitive decline. The study … Read more
Will it be the best thing since sliced bread? Keto is a high-fat, moderate-protein and low-carb diet designed to plunge the body into ketosis, where it burns fat instead of carbs for fuel. Dieters often shed up to 10 pounds the first two weeks — mainly water weight — while long-term loss is typically one … Read more
Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments. But in a surprising twist, top-line results show … Read more
Talk about a killer body. Across the country, a growing number of patients are turning to injectable fillers made from the dearly departed’s donated fat in order to lift, plump and sculpt their bodies — including for hot-ticket procedures like Brazilian butt lifts (BBL) and breast enhancements. “Many of us in New York City are … Read more
Parents are scrambling to secure a cheap generic cancer drug for their children after the Trump administration touted it as a potential treatment for autism symptoms in the fall. “I can’t even tell you how much of an influx we’ve had,” Dr. Richard Frye, a pediatric neurologist who studies the medication, called leucovorin, told The … Read more
Blockbuster weight-loss shots are undergoing a major makeover. Drugs like Zepbound and Wegovy have already taken the US by storm — with the number of Americans using them to slim down more than doubling over the past 18 months. And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new … Read more
“You may feel like you’re going to die — but you’re not. Your body is right here in this safe place and we are monitoring you to ensure you are safe.” That’s what Steph Mahrle, a 43-year-old stay-at-home mom from Bergen County, New Jersey, was told before her first ketamine therapy session at Nushama Wellness … Read more
Nathaniel Schnier had notes — years’ worth of them. Having spent much of his childhood barely able to mutter more than a few words at a time, the young boy began speaking in full sentences at age 8. His first order of business? Setting the record straight. “He had a laundry list of everything that … Read more
Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and the ability to perform simple tasks. Early attempts at treating or managing Alzheimer’s have concentrated on neurons and other brain cells. Newer approaches have been exploring how other … Read more
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to walk again after an … Read more
Ryan Baldridge Jr. was a bright, talkative toddler — breezing through flash cards, building an “astonishing” vocabulary and hitting developmental milestone with ease. Then, at 18 months, something shifted. “It was like he was erased and reset,” his father, Ryan Baldridge Sr., told The Post. “Everything changed.” Suddenly, the young boy, known to his family … Read more
A novel gene therapy has been found to significantly slow the progression of Huntington’s disease, offering new hope to sufferers of the incurable disorder that destroys brain cells over time. Drugmaker uniQure reported the results of its small but “groundbreaking” Phase I/II study this week, finding that a high dose of its AMT-130 therapy slowed … Read more
Needle-less to say, it’s effective! Eli Lilly’s experimental GLP-1 pill caused participants in a late-stage trial to shed an average of 10.5% of their body weight — nearly 23 pounds — over 16 months, according to data released Tuesday. The daily medication, known as orforglipron, has also been shown to reduce hemoglobin A1C —average blood … Read more
Life’s ruff enough without the added challenge of getting your pudgy pup or tubby tabby to slim down. America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight. The consequences are far from fluffy. Those extra pounds can lead to serious health issues, sky-high vet bills … Read more
An eight-year-old boy has regained his ability to walk with the aid of a compound found in a common over-the-counter supplement. The boy’s case was detailed in the journal Nature. The unnamed child was an active athlete until the summer of 2023, when he began to struggle with mobility. Within months, his symptoms progressed to the … Read more
Sit, stay… live longer? Research shows that owning a dog can help humans live longer, healthier lives. Now, a US biotech company wants to return the favor with anti-aging drugs designed to extend the lifespan of your canine companion. “The longevity space is crowded right now, and for good reason,” Celine Halioua, founder and CEO … Read more
A real ache-ievement! Duke University researchers have devised a promising, potent pain reliever — seemingly without the harmful side effects and addictive highs of opioids. While opioids interact with numerous cellular pathways, the experimental drug is more selective. SBI-810 targets a receptor in the brain and spinal cord, activating a single pain-relief signal while steering … Read more
A new once-daily pill may raise the bar for weight loss meds. Ozempic, Mounjaro and similar drugs that mimic the GLP-1 hormone the body naturally produces after eating can cause significant weight loss, but a potential side effect is loss of lean muscle mass. The makers of the experimental drug SYNT-101 claim it mimics the … Read more
Chronic lower back pain is one of the top complaints that sends Americans to their doctors — and it’s a leading cause of missed workdays and disability claims. While slipped discs, arthritis and spinal problems are often blamed, for some, the real culprit is an infection. Now, there’s hope on the horizon for these patients. … Read more
As scientists continue to investigate the roots of autism, a generic cancer drug might hold the key. Leucovorin is prescribed to reduce the side effects of chemo. But in several studies conducted over the past 13 years, Dr. Richard Frye has compiled growing evidence that it can improve signs of autism, even leading nonverbal children … Read more